The prevalence of various diseases across the globe is rising on a rapid pace. While some mild infections or diseases can be treated by taking proper medication, severe cases often create need for operations and surgeries. Such cases, among many serious cases including injuries, sometimes require blood transfusion. The awareness regarding blood donation has risen considerably, which is why numerous people donate blood, at times, regularly. It is now news that blood transfusion is a serious matter and medical professionals need to take utmost care before and during carrying of such a procedure.
Prior to the donation, blood donors are asked a set of questions for determining whether or not they are in a position to donate blood, as the blood needs to free of any kind of disease that can be transmitted during the transfusion. If the donor is eligible for donating, the donated blood is then tested for Rh type and blood type. All of the donated blood for transfusion is also tested for evidence of some specified infectious diseases, such as hepatitis C and B and human immunodeficiency virus. This is referred to as the blood screening process.
Request for sample copy of this report: https://www.psmarketresearch.com/market-analysis/blood-screening-market/report-sample
The technologies which are utilized for blood screening are next-generation sequencing, nucleic acid technology (NAT), western blotting, enzyme-linked immunosorbent assay, and rapid testing. Among these, the NAT technology is utilized the most, owing to the fact that this technology exhibits higher sensitivity as compared to other, thereby making is popular among facilities testing blood for quality. Different centers which conduct blood screening are ambulatory surgical centers, blood banks, clinics, diagnostic centers and pathology labs, and hospitals. Blood banks conducted the largest blood screening processes in the past due to the increasing organ transplant surgeries, blood donation activities, and awareness regarding the dangers of contaminated blood across the globe.
Geographically, North America emerged as the largest blood screening market in 2019, which is attributed to the surging incidence of infectious and respiratory diseases in the region. For example, the region has accounted for the largest number of COVID-19 cases and deaths, i.e. 560,000and 22,000, respectively, as of April 13th 2020. Other than this, the demand for blood screening is also predicted to rise considerable in the Asia-Pacific region in the near future. This is due to the presence of major players, rising incidence of cancer and other chronic diseases, and cost-effective labor.
Browse full report at: https://www.psmarketresearch.com/market-analysis/blood-screening-market
This Study Covers
• Historical and the present size of the blood screening market
• Future potential of the market through its forecast for the period 2020– 2030
• Major factors driving the market and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the blood screening market participants
• Historical and the present size of the market segments and understand their comparative future potential